scispace - formally typeset
K

Keiichi Uchida

Researcher at Mie University

Publications -  251
Citations -  3335

Keiichi Uchida is an academic researcher from Mie University. The author has contributed to research in topics: Ulcerative colitis & Colorectal cancer. The author has an hindex of 28, co-authored 241 publications receiving 2787 citations.

Papers
More filters
Journal ArticleDOI

Prognostic nutritional index predicts postoperative outcome in colorectal cancer.

TL;DR: Preoperative PNI is a useful predictor of postoperative complications and survival in patients with colorectal cancer and was an independent prognostic factor for poor survival in multivariate analysis for survival.
Journal ArticleDOI

In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model.

TL;DR: In septic mice, both anchored and cell-free NETs were significantly increased in postcapillary venules of the cecum and hepatic sinusoids with increased leukocyte-endothelial interactions, which may suggest the adverse effect of intravascular NETs on the host during a sepsis.
Journal ArticleDOI

Bioresorbable Hyaluronate-Carboxymethylcellulose Membrane (Seprafilm) in Surgery for Rectal Carcinoma: A Prospective Randomized Clinical Trial

TL;DR: Seprafilm effectively reduced abdominal adhesions in chemoradiated patients, and had no adverse effects on the oncologic results of fully introduced adjuvant therapy Thus, Seprafilm is a safe and effective tool for use in rectal carcinoma surgery.
Journal ArticleDOI

Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI

TL;DR: MRI shows features which were helpful for differentiating MPN ST from NF, and intra-tumoral lobulation and the presence of a high signal-intensity area on T1WI were critical indicators to differentiate MPNST from NF.
Journal ArticleDOI

Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.

TL;DR: BDNF/TrkB signaling may be a potential target for treating peritoneal carcinomatosis arising from colorectal cancer, and its therapeutic potential in vitro and in vivo.